Generic Oncology Sterile Injectable Market: Global Market Size, Forecast, Insights, and Competitive Landscape

The global generic oncology sterile injectable market is expected to grow at a CAGR of around 11.3% during 2022-2028. This report on global generic oncology sterile injectable market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global generic oncology sterile injectable market by segmenting the market based on size, product type, disease indication, distribution channel, and region. Also, detailed profiles of companies operating in the generic oncology sterile injectable market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision. 

Market Drivers 

• Increasing Launches of Drugs
• Rising Prevalence of Cancer

Market Challenges 

• Stringent Rules and Regulations for Manufacturing
• High Operational Costs

Historical & Forecast Period

Base Year: 2021

Historical Period: 2017-2020

Forecast Period: 2022-2028

Market by Product Type

• Chemotherapy
  o Alkylating Agents
  o Antimetabolites
  o Plant Alkaloids
  o Antitumor Antibiotics
  o Others
• Monoclonal Antibodies
• Cytokines
• Peptide Hormones

Market by Disease Indication

• Ovarian Cancer
• Breast Cancer
• Lung Cancer
• Pancreatic Cancer
• Others

Market by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market by Region

• Europe
  o Germany
  o United Kingdom
  o France
  o Italy
  o Spain
  o Russia
  o Netherlands
  o Rest of Europe
• North America
  o United States
  o Canada
• Asia Pacific
  o China
  o Japan
  o India
  o South Korea
  o Australia
  o Indonesia
  o Rest of Asia Pacific
• Latin America
  o Mexico
  o Brazil
  o Argentina
  o Rest of Latin America
• Middle East & Africa
  o Saudi Arabia
  o Turkey
  o Iran
  o United Arab Emirates
  o Rest of Middle East & Africa

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Generic Oncology Sterile Injectable Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Generic Oncology Sterile Injectable Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Generic Oncology Sterile Injectable Market by Product Type
5.1 Introduction
5.2 Chemotherapy
5.2.1 Alkylating Agents
5.2.2 Antimetabolites
5.2.3 Plant Alkaloids
5.2.4 Antitumor Antibiotics
5.2.5 Others
5.3 Monoclonal Antibodies
5.4 Cytokines
5.5 Peptide Hormones
6. Global Generic Oncology Sterile Injectable Market by Disease Indication
6.1 Introduction
6.2 Ovarian Cancer
6.3 Breast Cancer
6.4 Lung Cancer
6.5 Pancreatic Cancer
6.6 Others
7. Global Generic Oncology Sterile Injectable Market by Distribution Channel
7.1 Introduction
7.2 Hospital Pharmacies
7.3 Retail Pharmacies
7.4 Online Pharmacies
8. Global Generic Oncology Sterile Injectable Market by Region
8.1 Introduction
8.2 Europe
8.2.1 Germany
8.2.2 United Kingdom
8.2.3 France
8.2.4 Italy
8.2.5 Spain
8.2.6 Russia
8.2.7 Netherlands
8.2.8 Rest of the Europe
8.3 North America
8.3.1 United States
8.3.2 Canada
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 South Korea
8.4.5 Australia
8.4.6 Indonesia
8.4.7 Rest of the Asia Pacific
8.5 Latin America
8.5.1 Mexico
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 Turkey
8.6.3 Iran
8.6.4 United Arab Emirates
8.6.5 Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profile
12.2.1. Baxter International Inc.
12.2.2. Biocon Ltd.
12.2.3. Eli Lilly & Company
12.2.4. Hikma Pharmaceuticals PLC
12.2.5. Mylan N.V.
12.2.6. Pfizer Inc.
12.2.7. Sandoz International GmbH
12.2.8. Teva Pharmaceutical Industries Ltd.

List of Figures

Figure 1: Global Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 2: Global Generic Oncology Sterile Injectable Market by Product Type, 2020
Figure 3: Global Generic Oncology Sterile Injectable Market by Disease Indication, 2020
Figure 4: Global Generic Oncology Sterile Injectable Market by Distribution Channel, 2020
Figure 5: Global Generic Oncology Sterile Injectable Market by Region, 2020
Figure 6: Global Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 7: Global Generic Oncology Sterile Injectable Market by Product Type (in %), 2020 & 2027
Figure 8: Global Chemotherapy Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 9: Global Chemotherapy Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 10: Alkylating Agents Chemotherapy Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 11: Antimetabolites Chemotherapy Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 12: Plant Alkaloids Chemotherapy Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 13: Antitumor Antibiotics Chemotherapy Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 14: Other Chemotherapy Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 15: Global Monoclonal Antibodies Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 16: Global Monoclonal Antibodies Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 17: Global Cytokines Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 18: Global Cytokines Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 19: Global Peptide Hormones Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 20: Global Peptide Hormones Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 21: Global Generic Oncology Sterile Injectable Market by Disease Indication (in %), 2020 & 2027
Figure 22: Global Ovarian Cancer Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 23: Global Ovarian Cancer Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 24: Global Breast Cancer Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 25: Global Breast Cancer Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 26: Global Lung Cancer Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 27: Global Lung Cancer Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 28: Global Pancreatic Cancer Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 29: Global Pancreatic Cancer Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 30: Global Other Disease Indications Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 31: Global Other Disease Indications Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 32: Global Generic Oncology Sterile Injectable Market by Distribution Channel (in %), 2020 & 2027
Figure 33: Global Hospital Pharmacies Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 34: Global Hospital Pharmacies Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 35: Global Retail Pharmacies Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 36: Global Retail Pharmacies Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 37: Global Online Pharmacies Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 38: Global Online Pharmacies Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 39: Global Generic Oncology Sterile Injectable Market by Region (in %), 2020 & 2027
Figure 40: Europe Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 41: Europe Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 42: Europe Generic Oncology Sterile Injectable Market by Country (in %), 2020 & 2027
Figure 43: Germany Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 44: United Kingdom Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 45: France Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 46: Italy Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 47: Spain Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 48: Russia Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 49: Netherlands Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 50: North America Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 51: North America Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 52: North America Generic Oncology Sterile Injectable Market by Country (in %), 2020 & 2027
Figure 53: United States Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 54: Canada Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 55: Asia Pacific Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 56: Asia Pacific Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 57: Asia Pacific Generic Oncology Sterile Injectable Market by Country (in %), 2020 & 2027
Figure 58: China Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 59: Japan Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 60: India Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 61: South Korea Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 70: Australia Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 71: Indonesia Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 72: Latin America Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 73: Latin America Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 74: Latin America Generic Oncology Sterile Injectable Market by Country (in %), 2020 & 2027
Figure 75: Mexico Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 76: Brazil Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 77: Argentina Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 78: Middle East & Africa Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2020
Figure 79: Middle East & Africa Generic Oncology Sterile Injectable Market (in US$ Million), 2021-2027
Figure 80: Middle East & Africa Generic Oncology Sterile Injectable Market by Country (in %), 2020 & 2027
Figure 81: Saudi Arabia Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 82: Turkey Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 83: Iran Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 84: UAE Generic Oncology Sterile Injectable Market (in US$ Million), 2016-2027
Figure 85: Market Value Chain

List of Tables

Table 1: Global Generic Oncology Sterile Injectable Market Portraiture
Table 2: Global Generic Oncology Sterile Injectable Market by Product Type (in US$ Million), 2020 & 2027
Table 3: Chemotherapy Generic Oncology Sterile Injectable Market by Product Type (in US$ Million), 2020 & 2027
Table 4: Global Generic Oncology Sterile Injectable Market by Disease Indication (in US$ Million), 2020 & 2027
Table 5: Global Generic Oncology Sterile Injectable Market by Distribution Channel (in US$ Million), 2020 & 2027
Table 6: Global Generic Oncology Sterile Injectable Market by Region (in US$ Million), 2020 & 2027
Table 7: Europe Generic Oncology Sterile Injectable Market by Country (in US$ Million), 2020 & 2027
Table 8: North America Generic Oncology Sterile Injectable Market by Country (in US$ Million), 2020 & 2027
Table 9: Asia Pacific Generic Oncology Sterile Injectable Market by Country (in US$ Million), 2020 & 2027
Table 10: Latin America Generic Oncology Sterile Injectable Market by Country (in US$ Million), 2020 & 2027
Table 11: Middle East & Africa Generic Oncology Sterile Injectable Market by Country (in US$ Million), 2020 & 2027
Table 12: List of Key Players